Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis.

Keyphrases

• Multiple Sclerosis 100%
• CXCL10 100%
• Chemokine CXCL10 100%
• Intrathecal Inflammation 100%
• Differential Involvement 100%
• Chemokine CCL2 100%
• Chemokine Ligand 2 (CCL2) 87%
• Cerebrospinal Fluid Concentration 75%
• Cerebrospinal Fluid 50%
• Chemokines 37%
• Matrix metalloproteinase-9 (MMP-9) 25%
• Methylprednisolone 25%
• Intrathecal Synthesis 25%
• Inflammation 12%
• Randomized Controlled Trial 12%
• Placebo 12%
• Multiple Sclerosis Treatment 12%
• Tumefactive multiple Sclerosis 12%
• Monocyte Chemoattractant protein-1 (MCP-1) 12%
• Optic Neuritis 12%
• Enzyme-linked Immunosorbent Assay (ELISA) 12%
• Disease Pathogenesis 12%
• Leukocyte Count 12%
• Neopterin 12%
• IP-10 12%
• CNS Inflammation 12%
• Serial Analysis 12%

Neuroscience

• Multiple Sclerosis 100%
• Intrathecal 100%
• Gamma Interferon Inducible Protein 10 100%
• Monocyte Chemotactic Protein 1 100%
• CXCL10 100%
• CCL2 87%
• Chemokine 37%
• MMP9 25%
• Methylprednisolone 25%
• Placebo 12%
• Randomized Controlled Trial 12%
• Optic Neuritis 12%
• Leukocyte 12%
• Neopterin 12%
• Immunoglobulin M 12%
• Enzymes 12%